タイトル無し
スポンサーリンク
概要
- 論文の詳細を見る
<I>Objective</I>: In Japan, most people who have infection with HIV also have infection with HCV caused by administration of coagulation factor products. Fatal lactic acidosisrarely occurs in patients with HIV/HCV co-infection while using both HAART drugs and rivabirin. We experienced a patient with fatal hepatic failure following lactic acidosis after the use of both HAART drugs and rivabirin. We report this rare case with discussion of the results of postmortem examination.<BR><I>Case Report</I>: A 35-year-old man infected with HIV and HCV after administration of blood products for hemophilia A was started on anti-retroviral therapy for HIV in 1990. He was treated with d4T+ddI+PI (RTV+LPV) from January 2003 after several changes of anti-retroviral drugs. From September 2003, IFNα and ribavirin were also administered for treatment of HCV hepatitis. Symptoms of lactic acidosis initially appeared in October. Although the above-described medication was stopped and treatment for lactic acidosis, including intravenous administration of sodium bicarbonate, was started immediately, hepatic insufficiency rapidly progressed and he died in November 2003.<BR><I>Conclusion</I>: In this case, rapidly progressing hepatic insufficiency was induced bylactic acidosis. We concluded that hepatic failure was possibly caused by lactic acidosis, side effects of combined therapy with IFNα and ribavirin, and rapid progression to non-compensative liver cirrhosis from HCV hepatitis.
- 日本エイズ学会の論文
日本エイズ学会 | 論文
- 臨床 北関東甲信越地区の病院により管理されているHIV感染者の実態調査--歯科治療に関するアンケート調査から
- TDF開始後, 早期に高度の腎機能障害を呈した一例
- HCVのウイルス学 (特集:HIVとHCVの重感染)
- HIV感染症治療のガイドラインの変遷
- d4T, 3TC内服中に buffalo hump を認めたHIV感染血友病の一例